The Neighborly Drug Dealer

An Open Dialogue and Update on Azalea Drugs

28 min · 28. maj 2025
Billede af episoden An Open Dialogue and Update on Azalea Drugs

Beskrivelse

Join us on this special episode of The Neighborly Drug Dealer, as Dr. Morgan Fordham gives an update on Azalea Drugs and the pharmacy construction project.

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af The Neighborly Drug Dealer-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

22 episoder

Billede af episoden GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters

GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters

There’s been a lot of noise lately around semaglutide, tirzepatide, and other GLP-1 medications—especially as the FDA cracks down on certain compounded versions. But what’s really going on? And what should patients and providers know? In this solo episode, I unpack the truth behind the headlines. We’ll clarify what GLP-1 medications actually are (hint: they’re not insulin), why they’re in such high demand, and how compounding pharmacies legally stepped in during national shortages. I’ll also break down the difference between 503A and 503B pharmacies and share how to spot quality in compounded meds. Whether you’re a patient, provider, or pharmacy pro, this episode clears the fog around GLP-1s and gives you real tools to stay informed.

8. juli 202534 min